Podcast: Long-acting beta2-agonists for chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease is a common condition and causes the death of millions of people worldwide every year, and the Cochrane Airways Group has already produced several reviews. In October 2013, their collection has been added to with a review of the effects of long-acting beta-agonists. The lead author, Kayleigh Kew from St George’s Hospital in London England, tells us more.